Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial.
Saved in:
| Title: | Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial. |
|---|---|
| Authors: | Nicholls SJ; Victorian Heart Institute, Monash University, Clayton, Victoria, Australia. stephen.nicholls@monash.edu., Nelson AJ; Victorian Heart Institute, Monash University, Clayton, Victoria, Australia., Ditmarsch M; NewAmsterdam Pharma, Amsterdam, the Netherlands., Kastelein JJP; NewAmsterdam Pharma, Amsterdam, the Netherlands.; Department of Vascular Medicine, University of Amsterdam, Amsterdam, the Netherlands., Ballantyne CM; Baylor College of Medicine, Houston, TX, USA., Ray KK; Imperial College London, London, UK., Navar AM; UT Southwestern, Dallas, TX, USA., Nissen SE; Cleveland Clinic, Cleveland, OH, USA., Goldberg AC; Washington University School of Medicine, St Louis, MO, USA., Brunham LR; Department of Medicine and Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada., Wuerdeman E; NewAmsterdam Pharma, Amsterdam, the Netherlands., Neild AL; NewAmsterdam Pharma, Amsterdam, the Netherlands., Kling D; NewAmsterdam Pharma, Amsterdam, the Netherlands., Hsieh A; NewAmsterdam Pharma, Amsterdam, the Netherlands., Butters J; Victorian Heart Institute, Monash University, Clayton, Victoria, Australia., Ference BA; Centre for Naturally Randomized Trials, University of Cambridge, Cambridge, UK., Laufs U; Klinik und Poliklinik für Kardiologie, Leipzig University, Leipzig, Germany., Banach M; Medical University of Lodz, Lodz, Poland.; The John Paul II Catholic University of Lublin, Lublin, Poland., Mehran R; Mt Sinai School of Medicine, New York, NY, USA., Catapano AL; University of Milan and Multimedica IRCCS, Milan, Italy., Szarek M; University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; State University of New York Downstate School of Public Health, Brooklyn, NY, USA., Balinskaite V; Medpace, Cincinnati, OH, USA., Davidson MH; NewAmsterdam Pharma, Amsterdam, the Netherlands. |
| Source: | Nature medicine [Nat Med] 2026 May; Vol. 32 (5), pp. 1935. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
